NCT02824653View on ClinicalTrials.gov

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

December 31, 2016

Conditions
Graft Versus Host Disease
Interventions
BIOLOGICAL

Mesenchymal Stem Cells

Allogenic Human Bone Marrow Mesenchymal Stem Cells (ex-vivo expanded in pooled human platelet lysate)

Trial Locations (1)

46000

Armed Forces Bone Marrow Transplant Centre, Rawalpindi

All Listed Sponsors
lead

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

OTHER_GOV

NCT02824653 - Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD | Biotech Hunter | Biotech Hunter